Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;130(1):7-18.
doi: 10.1007/s00702-022-02564-8. Epub 2022 Nov 8.

Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review

Udo Bonnet  1   2 , Michael Specka  3 , Patrik Roser  3 , Norbert Scherbaum  3
Affiliations

Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review

Udo Bonnet et al. J Neural Transm (Vienna). 2023 Jan.

Abstract

The interaction between cannabis use or addiction and SARS-COV-2 infection rates and COVID-19 outcomes is obscure. As of 08/01/2022 among 57 evaluated epidemiological/clinical studies found in Pubmed-database, most evidence for how cannabis use patterns were influenced by the pandemic was given by two systematic reviews and 17 prospective studies, mostly involving adolescents. In this age group, cannabis use patterns have not changed markedly. For adults, several cross-sectional studies reported mixed results with cannabis use having increased, decreased or remained unchanged. Two cross-sectional studies demonstrated that the severity of adults´ cannabis dependence was either increased as a consequence of increasing cannabis use during the pandemic or not changed. Regarding the effect of cannabis use on COVID-19 outcomes, we found only five retrospective/cross-sectional studies. Accordingly, (i) cannabis use did not impact mild COVID-19 symptoms; (ii) cannabis using individuals experienced more COVID-19-related hospitalizations; (iii) cannabis using veterans were associated with reduced SARS-COV-2 infection rates; (iv) frequent cannabis use was significantly associated with COVID-19 mortality, and (v) cannabis dependents were at higher risk of COVID-19 breakthrough after vaccination. It should be outlined that the validity of these retrospective/cross-sectional studies (all self-reports or register/e-health-records) is rather low. Future prospective studies on the effects of cannabis use on SARS-COV-2 infection rates and COVID-19 outcomes are clearly required for conclusive risk-benefit assessments of the role of cannabis on users' health during the pandemic. Moreover, substance dependence (including cannabis) is associated with (often untreated) somatic comorbidity, which severity is a proven key risk factor for worse COVID-19 outcomes.

Keywords: COVID-19; Cannabis addiction; Cannabis use disorder; Hospitalization; Mortality; SARS-COV-2.

PubMed Disclaimer

Conflict of interest statement

N. Scherbaum has received honoraria for several activities (e.g., advisory board membership, lectures, manuscripts) from AbbVie, Camurus, Hexal, Janssen-Cilag, MSD, Medice, Mundipharma, Reckitt-Benckiser/Indivior, and Sanofi-Aventis. During the last three years he has participated in clinical trials financed by the pharmaceutical industry. M. Specka, P. Roser & U. Bonnet have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Assaf RD, Gorbach PM, Cooper ZD. Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic. Am J Drug Alcohol Abuse. 2022;48(3):321–327. doi: 10.1080/00952990.2021.2007257. - DOI - PMC - PubMed
    1. Balaram K, Marwaha R, Kaelber DC. The effects of substance use on severe acute respiratory syndrome coronavirus infection risks and outcomes. Curr Opin Psychiatry. 2021;34(4):386–392. doi: 10.1097/YCO.0000000000000711. - DOI - PMC - PubMed
    1. Bartel SJ, Sherry SB, Stewart SH. Self-isolation: a significant contributor to cannabis use during the COVID-19 pandemic. Subst Abus. 2020;41(4):409–412. doi: 10.1080/08897077.2020.1823550. - DOI - PubMed
    1. Blithikioti C, Nuño L, Paniello B, Gual A, Miquel L. Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: risk factors for adverse mental health outcomes. J Psychiatr Res. 2021;139:47–53. doi: 10.1016/j.jpsychires.2021.05.006. - DOI - PMC - PubMed
    1. Boehnke KF, McAfee J, Ackerman JM, Kruger DJ. Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic. Int J Drug Policy. 2021;92:103053. doi: 10.1016/j.drugpo.2020.103053. - DOI - PMC - PubMed

Publication types

Supplementary concepts